Skip to main content
. 2016 Dec 23;7:2038. doi: 10.3389/fmicb.2016.02038

Figure 1.

Figure 1

Distribution of fluconazole (A) and micafungin (B) MICs using Etest® for 268 clinical isolates of C. glabrata from 147 patients. Dotted line shows recently published EUCAST breakpoints for C. glabrata susceptibility.